A vaccine the world is waiting for: “It can change the lives of many”

A Solna laboratory is developing a vaccine that could save the lives of countless children in low- and middle-income countries. “Working on something that can m...

New diagnostic rules raise concerns

In a panel discussion, several voices from academia and the industry expressed concerns about the transition to the new regulatory framework for in-vitro diagno...

The Swedish innovation model: “There is a paradox”

It is often said that Sweden is strong when it comes to innovation, but how well are we turning that innovation into actual medicines?

Nordic Regulatory experts: Improving biotech chances of Succ

Why is it that so many biotech companies fail? And what are the tools needed to change that fact?

How to optimise your liquid handling results

In dispensing or pipetting applications in laboratory automation, it is important to obtain reliable results, which are analysed by calculating the accuracy and...

Avancerade terapier på frammarsch – ”Utmaningarna är stora”

Utvecklingen av läkemedel för avancerad terapi sker snabbt och runt om i landet startas nu flera centrum för att tillgängliggöra den nya läkemedelsgruppen. Möjl...

Addvise i miljonavtal

Två dotterbolag till Addvise tecknar nytt distributionsavtal med libanesiska Alpha Pro.

Marie Gårdmark: Potential step change – EU regulators get to play with data

A new pilot from EMA is starting in September to assess wether the analysis of 'raw data' by regulatory authorities improves the evaluation of marketing approva...

Anna Törner: ”Orphan Designation – the "petite robe noire" of drug development”

It is easy to cling to various regulatory incentives, like orphan designation, and other expedited pathways, without understanding what they truly mean or wheth...

New report: Fewer PhDs in life sciences

A new report from Vinnova suggests that competency returns in the life science sector are declining.

Pfizer’s record year – topped the $100 billion mark

In 2022 Pfizer, as the first pharmaceutical company in history, reached an annual revenue of more than 100 billion dollars, thereby surpassing Johnson & Johnson...

From Valneva to the CEO position at NorthX – “I saw it as a great opportunity”

A new cell therapy for leukaemia, a vaccine in tablet form against cholera, and a proprietary mRNA line with the potential capacity to supply the entire Nordic ...

Webinar: What is Regulatory Affairs?

This webinar is intended for those who work within the life science sector and would like to gain a general understanding of regulatory affairs for human medicinal products.

The Swedish National Board of Health and Welfare rejects prioritising andrology as a speciality

Male infertility can be linked to a shorter lifespan and several severe diseases, but when couples who want children are examined, the focus is on the woman. Ex...

SMC lanserar världens smalaste magnetventil

Med robot-integratörer och maskinbyggare i åtanke lanserar SMC världens smalaste magnetventil. JSY:s låga vikt och små byggmått sparar energi/plats i rörliga ap...

Oasmia tar in 151 miljoner – och byter namn

Styrelsen i cancerforskningsföretaget Oasmia har beslutat om en nyemission på 151 miljoner kronor. Samtidigt föreslås ett namnbyte av företaget till Vivesto.

Unilabs får ny Sverige-vd

Diagnostikleverantören Unilabs Sverige har utsett Sanna Rydberg till ny vd.

Alert from the Swedish Medicines Agency: Many complications with gastric balloons

According to the Swedish Medicines Agency, an increasing number of serious complications are being reported in procedures with gastric balloons as a method for ...

Energibesparing med Wilden

Wildens unika och patenterade luftsystem Pro-Flo Shift® ger upp till 60% besparing av drivluft.

Søren Bregenholt omvald som ordförande i MVA

Under Medicon Valley Alliance årsstämma fick styrelsen förnyat förtroende och valdes om.

Oncopeptides läkemedel godkänt i Storbritannien

Quiet, fast, inexpensive: mass flow controller for life sciences

Whether in portable oxygen system devices or in bioreactors, the new proportional flow control valve VEMD from Festo provides extremely high control dynamics an...

The government proposes fines for pharmaceutical companies that fail to notify drug shortages in time

According to a compilation from the Swedish Medicines Agency, the number of residually notified medicines increased by 54 % in Sweden last year compared to the ...

”Vi måste säkerställa att alla medborgare får tillgång till nya behandlingar”

Idag är behandlingar som gavs för två år sedan redan obsoleta och inget tyder på att vi nått en platå vad gäller nya terapier. Det anser Läkemedelsverkets gener...